Draft recommendations based on major gaps between the current and preferred status of HTA implementation in Oman according to the eight domains of the scorecard survey
| Domain | Recommendations |
|---|---|
| Capacity building | More graduate and postgraduate HTA programs are recommended based on country-specific needs |
| HTA funding | Sufficient public funding should be allocated to HTA assessment. HTA critical appraisals should be funded partially but not only by submission fees (private funding) |
| Legislation on HTA | Establishment of a public HTA agency supported by academic efforts with major reliance on local HTA evidence. OR: Establishment of multiple HTA agencies with central coordination with major reliance on local HTA evidence |
| Scope of HTA implementation | Extending the scope of HTA from pharmaceuticals to non-pharmaceuticals is recommended in addition to revising previous policy decisions on top of evaluating new healthcare technologies |
| Decision criteria | For cost-effectiveness, explicit soft thresholds should be used. Cost-effectiveness, budget impact and therapeutic value should be the main decision categories. In addition, other criteria other should be considered by applying multi-criteria decision analysis (MCDA) |
| Quality and transparency | Using published methodological guidelines for HTA/economic evaluation and checklists for critical appraisal is recommended to improve HTA work quality. HTA reports, critical appraisals and HTA recommendations should be published to maintain transparency. In addition, HTA submission should be accepted continuously with clear timelines for recommendations |
| Use of local data | Local data should be mandatory and the assessment of transferability of international evidence when submitting the research for appraisal. Developing more patient registries and utilizing local claims data is recommended with the availability of an accessible electronic payer’s database |
| International collaboration | Organizing and participating in international HTA courses is highly recommended as well as adapting work performed by other HTA bodies |
| Domain | Recommendations |
|---|---|
| Capacity building | More graduate and postgraduate HTA programs are recommended based on country-specific needs |
| HTA funding | Sufficient public funding should be allocated to HTA assessment. HTA critical appraisals should be funded partially but not only by submission fees (private funding) |
| Legislation on HTA | Establishment of a public HTA agency supported by academic efforts with major reliance on local HTA evidence. OR: Establishment of multiple HTA agencies with central coordination with major reliance on local HTA evidence |
| Scope of HTA implementation | Extending the scope of HTA from pharmaceuticals to non-pharmaceuticals is recommended in addition to revising previous policy decisions on top of evaluating new healthcare technologies |
| Decision criteria | For cost-effectiveness, explicit soft thresholds should be used. Cost-effectiveness, budget impact and therapeutic value should be the main decision categories. In addition, other criteria other should be considered by applying multi-criteria decision analysis (MCDA) |
| Quality and transparency | Using published methodological guidelines for HTA/economic evaluation and checklists for critical appraisal is recommended to improve HTA work quality. HTA reports, critical appraisals and HTA recommendations should be published to maintain transparency. In addition, HTA submission should be accepted continuously with clear timelines for recommendations |
| Use of local data | Local data should be mandatory and the assessment of transferability of international evidence when submitting the research for appraisal. Developing more patient registries and utilizing local claims data is recommended with the availability of an accessible electronic payer’s database |
| International collaboration | Organizing and participating in international HTA courses is highly recommended as well as adapting work performed by other HTA bodies |
Source(s): Authors work